Neil Minkoff, MD

Neil Minkoff; Natasha Mesinkovska, MD; and Brett King, MD, PhD discuss the diagnosis and disease assessment in alopecia areata along with clinical considerations.

Implications of Telehealth Use on the Future of Oncology Care

The rise of telehealth during COVID-19, its limitations, and its uncertain future.

Payer decision-makers discuss defining value among agents for unintended pregnancy, uterine fibroids, and endometriosis.

A panel of experts discuss treatment selection among contraceptive agents and evolving treatment strategies for uterine fibroids and endometriosis.

Ayman Al-Hendy, MD, PhD identifies risk factors for development of US and endometriosis.

Kevin Stephens, Sr. MD, JD examines key drivers of healthcare utilization for women of childbearing years.

Steven McCarus, MD FACOG highlights the shift away from surgical treatment toward medical therapy in UF and endometriosis.

Dr Lopes, OB-GYN and payer, discusses a focus on screening and prevention and availability of contraception among health plans in women’s health.

Ayman Al-Hendy, MD, PhD and Maria Lopes, MD, MS discuss common concerns that women seek care for during their reproductive years, including uterine fibroids, endometriosis, and unintended pregnancy.

Closing out their discussion on glaucoma management, experts share practical advice for care providers and payers alike.

Shared insight on how the use and sequencing of therapies for glaucoma will evolve in coming years.

Expert panelists review the use of MIGS and other channel procedures in patients with glaucoma.

A review of selective laser trabeculoplasty in glaucoma management, and when it is appropriate to consider as a treatment option.

A review of the novel sustained release approach with bimatoprost implants and how this is affecting glaucoma management.

Panelists discuss the role of rho kinase inhibitors in glaucoma management respective to cost, efficacy, and ease of use.

Shared insight on the importance of patient adherence in glaucoma management, and how this is influenced by therapeutic regimens.

Expert perspectives on the factors that inform therapy selection when managing patients with glaucoma.

Experts debate the use of generic agents over branded therapy when managing patients with glaucoma.

A broad review of therapeutic classes approved for the management of glaucoma and how they may be sequenced.

Following a brief discussion on utilization management, experts discuss the current paradigm of patient access to therapy.

Experts highlight early detection and the goals of therapy when managing patients with glaucoma.

A brief overview of vision preservation in glaucoma and the importance of preventing peripheral vision loss and patient falls.

Panelists discuss the worldwide gaps in diagnosis of glaucoma and how this negatively affects patient outcomes.

Shared insight on factors that put patients at risk for glaucoma and how screening can improve early diagnosis and care.

Closing out their discussion on recurrent clostridium difficile infection management, experts share closing thoughts and hopes for the future.

Panelists review unmet needs in clostridium difficile infection management and consider how medical policies are evolving to address them.

Shared insight on the process to gain access to fecal microbiota transplant for patients with clostridium difficile infection.